A phase 1/2 dose-escalation and dose-expansion study of ZN-c3 in combination with gemcitabine in adult and pediatric subjects with relapsed or refractory osteosarcoma Meeting Abstract
| Authors: | Avutu, V.; Slotkin, E. K.; Livingston, J. A. A.; Chawla, S. P.; Pressey, J. G.; Nandkumar, P.; Zheng, C.; Misir, S.; Pultar, P.; Voliotis, D.; Thornton, K. A.; Federman, N. |
| Abstract Title: | A phase 1/2 dose-escalation and dose-expansion study of ZN-c3 in combination with gemcitabine in adult and pediatric subjects with relapsed or refractory osteosarcoma |
| Meeting Title: | 2022 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 40 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2022 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2022-06-01 |
| Language: | English |
| ACCESSION: | WOS:000863680304792 |
| PROVIDER: | wos |
| DOI: | JCO.2022.40.16_suppl.TPS11584 |
| Notes: | Meeting Abstract: TPS11584 -- This meeting was also held virtually -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work